Modification of inflammatory mediators in intestinal ischemia-reperfusion in a model of type II diabetes;Modificación de los mediadores inflamatorios en isquemia-reperfusión intestinal en un modelo de diabetes tipo 2

Cirugia Espanola

Volumn 71, Issue 6, 2002, Pages 276-286

  Garcia Perez J C ^a   Arias, J ^a   Garcia C ^a   Vara, E ^a   Balibrea, J L ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Intestinal ischemia reperfusion; Type II diabetes

Indexed keywords

EID: 84897585322     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(02)71981-7     Document Type: Article

References (62)

1. Angulo J, Sánchez-Ferrer CF, Peiro C, Marín J, Rodríguez-Mañas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin. Possible mechanisms involved. Hypertensión 1996;28:583-92.
2. Anne-Cécile D, Serri O, Genevieve R. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment. Diabetes Care 1998;21:487-93.
3. Baigrie RJ, Lamont PM, Dallman M, Morris PJ. The release of interleukin-1β (IL-1) precedes that of interleukin 6 (IL-6) in patients undergoing major surgery. Lymphokine Res 1991;10:253-6.
4. Baigrie RJ, Lamont PM, Kwiatkoeski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg 1992;79: 757-60.
5. Baumgartner SM, Wagner L, Pettermann M, Gessl A, Waldhausl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 1995;38:1367-70.
6. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989;169:1467-72.
7. Campbell IL, Cutri A, Wilson A, Harrison LC. Evidence for IL-6 production by and effects on the pancreatic beta cell. J Immunol 1989;143:1188-91.
8. Cavallo MG, Pozzili P, Bird C, Wadwa M, Meager A, Visalli N, et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 1991;86:256-9.
9. Conjer J, Robinette J, Villar A, Raij L, Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest 1995;96:631-8.
10. Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL. Hepatocytes produce nitrogen oxides fron L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-74.
11. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen and reactive intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-12.
12. Fong Y, Moldawen LL, Shires T, Lowry SF. The biologic characteristics of cytokines and their implication in surgical surgery injury. Surg Gynecol Obstet 1990;170:363-78.
13. Freedman SF, Hatchell DL. Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes. Exp Eye Res 1992;55:767-73.
14. Friedl HP, Till GO, Ryan US. Mediator-induced activation of xanthine-oxidase in endothelial cells. FASEB J 1989;3:25112-8.
15. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-67.
16. Goor Y, Peer G, Iaina A, Blum M, Wollman Y, Chernihovsky T, et al. Nitric oxide in ischemia acute renal failure of streptozotocin diabetic ratas. Diabetologia 1996;39:1036-40.
17. Grisham MB, Hernández LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251:G567-74.
18. Holley AE, Cheesseman KH. Measuring free radical reactions in vivo. Br Med Bull 1993;49:494-505.
19. Hotamisligil GS. The role of TNFα and TNF receptors in obesity and insulin resistance. J Int Med 1999;245:621-5.
20. Huk I, Nanobash J, Neumayer CH, Partyka L, Malinski T. Bioflavonoid quercentin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surgery 1998;85:1080-5.
21. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996;39: 60-9.
22. Jennings PE, Scott NA, Saniabadi AR, Belch JJF. Effects of glicazide on platelet reactivity and free radicals in type II diabetic patients. Clinical assessment. Metabolism 1992;41:36-9.
23. Kelly LW, Barden CA, Tiedeman JS, Hatchell DDL. Alterations in viscosity and filterability of whole blood and blood cell subpopulation in diabetic cats. Exp Eye Res 1993;56:341-7.
24. Kobayashi H, Nonami T, Kurokawa T, Takeuchi Y, Harada A, Nakao A, et al. Role of endogenous nitric oxide in ischemia-reperfusión injury in rat liver. J Surg Res 1995;59:772-9.
25. Korthuis RJ, Smith JK, Carden DL. Hypoxic reperfusion attenuates postichemic microvascular injury. Am J Physiol 1989;256: H315-21.
26. Lo SK, Janakidevi K, Malik AB. Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol 1993;264:L406-12.
27. Marzi I, Zhong Z, Zimmermann FA, Lemaster JJ, Thurman RG. Xanthine and hipoxanthine accumulation during storage injury may contribute to reperfusion injury following liver transplantation in the rat. Transplant Proc 1989;21:1319-20.
28. Matheis G, Sherman MP, Buckberg GD, Hybron DM, Young HH, Ignarro LJ. Role of L-arginine nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-20.
29. McEver RP. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991;45:156-61.
30. Megison SM, Horton JW, Chao H, Walker P. A new model for intestinal ischemia in the rat. J Surg Res 1990;49:168-73.
31. Nguyen P, Durlach V, Leutenegger M, Guenounou M, Potron G. Explosion respiratoire des polynucléaires neutrophiles et profil des cytokines chez le diabétique non insulinodépendant. J Mal Vasc 1995;20:102-5.
32. Nilsson UA, Lundgren O, Haglind E, et al. ESR-measurement of radical production during in vivo intestinal ischemia and reperfusion in the cat. Am J Physiol 1989;257:G409-14.
33. Panés J, Kurose I, Rodríguez-Vaca MD, Anderson C, Miyasaka M, Tso P, et al. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 1996;93:161-7.
34. Paredi P, Biernacki W, Invernizzi G, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest 1999;116:1007-11.
35. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Phisiol 1986;250:G749-53.
36. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Speigelman BM. Tumor necrosis factor (TNFα) inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996;271:13018-22.
37. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hipertension 1998;31:1047-60.
38. Ragnar H, Alm P, Ekström P, Lundquist I. Hemo oxygenase and carbon monoxide: Regulatory roles in islet hormone release. Diabetes 1999;48:66-76.
39. Rapoport MJ, Mor A, Vardi P, Ramot Y, Winker R, Hindi A, et al. Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun 1998;11:635-42.
40. Rodríguez-Mañas L, Angulo J, Peiro C, Llergo JL, Sánchez-Ferrer A, López-Doriga P, et al. Endothelial dysfuntion and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 1998; 123:1495-502.
41. Rothlein R, Mainolgi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-93.
42. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992;6:2905-14.
43. Sandra A, Streamson C, Renée C. Obesity and diabetes in TNFα receptor-deficient mice. J Clin Invest Jul 1998;102:402-11.
44. Santini SA, Marra G, Giardino B, Cotroneo P, Mordente A, Martorana GE, et al. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997;46:1853-8.
45. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979;21:104-7.
46. 2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production. Diabetologia 1999;42:167-76.
47. Schoenberg MH, Fredholm BB, Haglund U, Jung H, Sellin D, Younes M, et al. Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage. Acta Physiol Scand 1985; 124:581-9.
48. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxicity activity of tumor necrosis factor is mediated by earlt damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992; 267:5317-23.
49. Sekizuka K, Tomino Y, Sei C, Kurusu A, Tashiro K, Yamaguchi Y, et al. Detection of serum IL-6 in patients with diabetic nephropathy. Nephron 1994;68:284-5.
50. Simpson R, Alon R, Kobzik L, Valeri R, Shepro D, Hechtman HB. Neutrophil and non-neutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 1993;218:444-54.
51. Takano T, Honma K, Maeda H. Endogenous carbon monoxide production in alloxanized rats. Bull Tokyo Med Dent Univ 1977;24:1.
52. Tatsishi T, Yoshimine N, Kuzuya F. Serum lipid peroxide assayed by a new colorimetric method. Exp Gerontol 1987;22:103-11.
53. Teoman K, Sarah M, Hotamisligil GS. Functional analysis of tumor necrosis factor (TNF) receptors in TNFα mediated insulin resistance in genetic obesity. Endocrinology 1998;139:4832-8.
54. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 1994;16:383-91.
55. Vaisman N, Schattner A, Hahn T. Tumor necrosis factor production during starvation. Am J Med 1989;87:115.
56. Vara E, Arias-Díaz J, García C, Hernández J, García-Carreras C, Cuadrado A, et al. Production of TNFα, IL-1, IL-6 and nitric oxide by islated human islets. Transplant Proc 1995;26:3367-71.
57. Welbourn CRB, Young Y. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 1992;79:998-1003.
58. Wierusz-Wysocka B, Wysochi H, Siekierba H, Wykretowicz A, Sczepanic A, Klimas R. Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus. J Leukoc Boil 1987;42:519-23.
59. Wolff DG, Bidlack WR. The formation of carbon monoxide during peroxidation of microsomal lipids. Biochem Biophys Res Commun 1976;73:850-7.
60. Yamada K, Takane N, Otabe S, Inada C, Inoue M, Nonaka K. Pancreatic β-cell-selective production of tumor necrosis factor α induced by interleukin-1. Diabetes 1993;42:1026-31.
61. Yu L, Genaro PE, Niederberger M, Burke TJ, Schrier RW. Nitric oxide: a mediator in the rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994;91:1691-5.
62. Zimmerman BJ, Holt JW, Paulson JC, Anderson DC, Miyasaka M, Tamatani T, et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am J Physiol 1994;246:H847-53.